Adalimumab use in Paediatric Inflammatory Bowel Disease: A single centre real-life experience

被引：0
|
作者：
El-Lababidi, N. [1 ,2 ]
Fruhauf, P. [2 ]
机构：
[1] General Univ Hosp Prague, Dept Paediat & Inherited Metab Disorders, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Prague, Czech Republic
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P596
引用
收藏
页码：I531 / I532
页数：2
相关论文
共 50 条
  • [1] Adalimumab use in Paediatric Inflammatory Bowel Disease: A single centre real-life experience
    El-Lababidi, N.
    Fruhauf, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I531 - I532
  • [2] Efficacy of adalimumab in mild-to-moderate inflammatory bowel disease: Real-life data from single-centre experience in the long-term period
    Akyuz, F.
    Ormeci, A.
    Namazova, N.
    Guzel, M.
    Abbasgoulizadeh, A.
    Tahincioglu, L.
    Alaskarli, S.
    Gurel, E.
    Bilgin, E.
    Atasoy, A.
    Cavus, B.
    Demir, K.
    Besisik, F.
    Kaymakoglu, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S329 - S330
  • [3] Thromboembolism in paediatric inflammatory bowel disease- A single centre experience
    Cheah, E.
    Fam, W.
    Lee, C.
    Magoffin, A.
    Dutt, S.
    Stormon, M.
    Gaskin, K.
    O'Loughlin, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 192 - 192
  • [4] Use of MRI-Enterography in Phenotyping of Paediatric Inflammatory Bowel Disease - A Single Centre Experience
    Grover, Zubin
    Muir, Richard
    Sarikwal, Anubhav
    Ee, Looi C.
    Withers, Geoffrey D.
    Lewindon, Peter
    GASTROENTEROLOGY, 2010, 138 (05) : S523 - S523
  • [5] Efficacy and safety of vedolizumab in inflammatory bowel disease: Real-life experience
    Gonzalez Munoza, C.
    Mesonero, F.
    Bargallo, A.
    Clos, A.
    Arajol, C.
    Gordillo, J.
    Lopez-San Roman, A.
    Guardiola, J.
    Navarro-Llavat, M.
    Bertoletti, F.
    Fernandez, C.
    Domenech, E.
    Garcia-Planella, E.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S486 - S486
  • [6] Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy
    Sartini, Alessandro
    Scaioli, Eleonora
    Liverani, Elisa
    Bellanova, Matteo
    Ricciardiello, Luigi
    Bazzoli, Franco
    Belluzzi, Andrea
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (03) : 863 - 874
  • [7] Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy
    Alessandro Sartini
    Eleonora Scaioli
    Elisa Liverani
    Matteo Bellanova
    Luigi Ricciardiello
    Franco Bazzoli
    Andrea Belluzzi
    Digestive Diseases and Sciences, 2019, 64 : 863 - 874
  • [8] Real-world quality of life experience of subcutaneous infliximab use in children with Inflammatory Bowel Disease (IBD) at a tertiary paediatric centre
    Dutt, S.
    Chidgey, T.
    Chuah, C. W.
    Eldredge, J.
    Magoffin, A.
    Puppi, J.
    Siew, S.
    Singh, N.
    Stormon, M.
    Tano, M.
    Thacker, K.
    O'Loughlin, E. V.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2163 - i2163
  • [9] Paediatric Integrase Inhibitor Use in a Real-Life Setting: A Single-Centre Cohort Experience 2009–2018
    Yara-Natalie Abo
    Erika Refsum
    Nicola Mackie
    Hermione Lyall
    Gareth Tudor-Williams
    Caroline Foster
    Clinical Drug Investigation, 2019, 39 : 585 - 590
  • [10] The impact of vedolizumab on extra-intestinal manifestations in inflammatory bowel disease patients: A real-life experience of a single-centre cohort
    Truyens, M.
    Geldof, J.
    Dewitte, G.
    Glorieus, E.
    Varkas, G.
    Elewaut, D.
    Ortega, T. Lobaton
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S546 - S547
12345